Momentive & SSF collaborate on medical device applications

ERJ staff report (LMH)

Albany, New York -- Momentive Performance Materials Inc. is to collaborate with Specialty Silicone Fabricators (SSF) to develop combination products for medical devices manufacturers, Momentive said in an 18 May statement.

Focusing on the fast-growing market of combination devices with Active Pharmaceutical Ingredients (APIs), Momentive said the collaboration brings together its advanced silicone elastomer technology with SSF expertise in silicone extrusion and medical device assembly.

The collaboration will use Momentive's ultraviolet (UV) elastomer cure technology, which the company claimed typically offers fast cure of specialised silicone products at room temperature. Products such as Momentive's Addisil UV 60 EX elastomer will be considered as part of the collaboration.

“Silicone is an ideal matrix material to consider for a wide range of healthcare applications, and our UV cure technology will enable manufacturers to consider a much broader range of ingredients in their silicone mixtures,” said Lynn Colucci-Mizenko, Global Marketing Director at Momentive. “We have conducted successful trials with SSF to optimise the UV curing extrusion process, and the results have confirmed our high expectations.”

The combined focus also takes advantage of SSF's experience and capabilities in the manufacture of custom silicone components and parts for the medical devices industry, including a Class 10 000 clean room for handling pharmaceutical components, Momentive said.

Licensed to operate as a drug manufacturing facility and registered with the US Food and Drug Administration's (FDA) Centre for Drug Evaluation and Research, SSF is planning to expand its API/drug eluting device production into another clean room that will house its own extrusion line and a larger press to meet growing customer demand.

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from Momentive